Vedolizumab in the Prophylaxis of Intestinal Acute Graft vs Host Disease in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
about
Vedolizumab in the Prophylaxis of Intestinal Acute Graft vs Host Disease in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
description
clinical trial
@en
klinisch onderzoek
@nl
name
Vedolizumab in the Prophylaxis ...... ll (Allo-HSCT) Transplantation
@en
type
label
Vedolizumab in the Prophylaxis ...... ll (Allo-HSCT) Transplantation
@en
prefLabel
Vedolizumab in the Prophylaxis ...... ll (Allo-HSCT) Transplantation
@en
P6153
P1476
A Randomized, Double-Blind, Pl ...... etic Stem Cell Transplantation
@en
P17
P3098
NCT03657160
P4844
P580
2019-01-28T00:00:00Z
P582
2020-10-23T00:00:00Z